#Japan #Tokyo #3D imaging #Carl Zeiss #X-ray microscopy

A Glimpse into the Future of 3D Bioimaging

On August 21, 2026, Carl Zeiss Corporation celebrated a remarkable seminar at their Tokyo office, focusing on the utilization of Electron Microscopy (EM) and X-ray Microscopy (XRM) in life sciences research. The event drew around 40 researchers, all of whom were eager to delve into the latest advancements in 3D observation and analysis technologies. Participants engaged in energetic discussions about a range of research examples, reflecting a vibrant exchange of ideas and insights.

Growing Demand for 3D Observations in Life Sciences

Today’s life sciences research is increasingly focused on comprehending complex structures and functions of cells and tissues. This has amplified the demand for high-resolution and three-dimensional observation techniques. Traditional optical microscopes may fail to capture intricate structural information, but EM and XRM provide innovative methods to visualize biological processes, facilitating deeper understandings of life phenomena and expediting research progression.

ZEISS has established itself as a pioneer by offering comprehensive solutions that cater to the needs of life sciences research. Their approach ranges from traditional optical microscopes to advanced electron and X-ray microscopes, correlation microscopy technologies, and AI-powered image analysis software. This seminar aimed not only to showcase the potential of EM and XRM within the research community but also to foster collaboration and networking among researchers.

The Second Edition of an Impactful Seminar Series

Building on the success of an inaugural seminar held the previous year, which received positive feedback from approximately half the participants expressing interest in exploring EM and XRM, the second edition brought together three distinguished researchers leading the charge in 3D observation and analysis technologies. Their presentations included the latest research results and practical applications, enriching the participants’ experience. The audience was treated to an engaging question-and-answer session following the presentations, which allowed attendees to deepen their understanding in relation to their respective research themes.

Featured Speakers and Presentation Topics

• - Nobuhiko Ohno, Professor of Anatomy at Jichi Medical University: Discussed the world of 3D morphology through SBF-SEM, connecting molecules and morphology to unveil the essence of life phenomena.
• - Shinsuke Shibata, Professor of Microscopic Anatomy at Niigata University: Shared insights into research utilizing MultiSEM technology.
• - Tetsuya Iwase, Senior Researcher at RIKEN: Explained the internal structure of callus tissue, revealing secrets behind plant regeneration capabilities.

After the presentations, the networking session buzzed with active discussions, leading to a fruitful exchange of knowledge and perspectives among attendees.

Introduction of ZEISS Solutions

During the seminar, ZEISS presented its array of offerings, including high-capacity 3D imaging through electron microscopes, non-destructive 3D imaging via X-ray microscopy, and advanced imaging analysis software powered by AI. Participants expressed their appreciation for the opportunity to hear firsthand accounts from researchers and gain valuable insights from different fields. Many attendees highlighted their interest in learning more about research case studies involving Focused Ion Beam Scanning Electron Microscopy (FIB-SEM).

Looking Ahead

ZEISS is committed to continuing its efforts in collaboration with life sciences researchers by sharing the potential of cutting-edge imaging technologies and providing innovative solutions that advance research capabilities. As a leading international company established in 1846, ZEISS continues to innovate across various sectors, including semiconductor manufacturing, industrial quality assurance, medical technology, and consumer markets, with a solid commitment to research and development.

About ZEISS

Since its inception, ZEISS has grown into a globally recognized leader in optical technology, with a diverse portfolio spanning four segments: Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets. With approximately €12 billion in revenue as of September 2025, ZEISS invests about 15% of its annual revenues back into R&D, ensuring the continuous evolution of its innovative contributions worldwide. The company operates with around 46,600 employees, 40 R&D facilities, 30 production sites, and around 60 sales and service companies across nearly 50 countries by September 2025. Furthermore, the Carl Zeiss Foundation, which owns ZEISS, is one of the largest German foundations dedicated to advancing science.